Dogwood Therapeutics, Inc.
Datakwaliteit: 83%
DWTX
Nasdaq
Manufacturing
Chemicals
€ 2,00
▲
€ 0,06
(3,09%)
Marktkapitalisatie: 66,59 M
Prijs
€ 2,00
Marktkapitalisatie
66,59 M
Dagbereik
€ 1,97 — € 2,11
52-Weeksbereik
€ 1,77 — € 9,50
Volume
37.586
Openen € 2,06
50D / 200D Gem.
€ 2,82
29,07% below
50D / 200D Gem.
€ 4,60
56,49% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -15,62 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-484,66%
Onder sectorgemiddelde (-51,02%)
ROIC-23,99%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio4,49
Interest CoverageN/A
Waardering
PE (TTM)
-1,94
Boven sectorgemiddelde (-1,98)
P/B Ratio9,17
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (44 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (44 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,9 | -2,0 |
| P/B | 9,2 | 5,1 |
| ROE % | -484,7 | -51,0 |
| Net Margin % | — | -150,2 |
| Rev Growth 5Y % | — | 9,3 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -34,26 M |
| ROE | -484,66% | ROA | -36,31% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -15,62 M |
| ROIC | -23,99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4,49 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 9,06 M | Tangible Book Value | -72,87 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1,94 | Forward P/E | N/A |
| P/B Ratio | 9,17 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -23,45% | ||
| Market Cap | 66,59 M | Enterprise Value | 56,46 M |
| Per Share | |||
| EPS (Diluted TTM) | -7,13 | Revenue / Share | N/A |
| FCF / Share | -0,47 | OCF / Share | -0,47 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 45,59% |
| SBC-Adj. FCF | -15,96 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -34,26 M | -12,35 M | -5,30 M | -12,25 M | -15,96 M |
| EPS (Diluted) | -7,13 | -12,52 | -0,28 | -1,11 | -1,92 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -27,97 M | -12,23 M | -5,45 M | -12,32 M | -15,64 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 21,87 M | 3,53 M | 1,73 M | 8,07 M | 10,80 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | 150.904,0 | 67.475,0 | 5.672,0 |
| Income Tax | 221.096,0 | -503,0 | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90,17 M | 94,31 M | 4,17 M | 8,37 M | 15,78 M |
| Total Liabilities | 15,27 M | 30,03 M | 358.548,0 | 1,04 M | 1,28 M |
| Shareholders' Equity | 74,90 M | -10,12 M | 3,81 M | 7,33 M | 14,50 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 6,52 M | 14,85 M | 3,32 M | 7,03 M | 14,01 M |
| Current Assets | 8,43 M | 16,54 M | 4,17 M | 8,37 M | 15,78 M |
| Current Liabilities | 3,06 M | 3,18 M | 358.548,0 | 1,04 M | 1,28 M |
{"event":"ticker_viewed","properties":{"ticker":"DWTX","listing_kind":"stock","pathname":"/stocks/dwtx","exchange":"Nasdaq","country":"US"}}